NASDAQ · Biotechnology

Crispr Therapeutics AG (CRSP)

$51.42 -5.23%

48 In band Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$53.20-3.35%

Company profile

CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.

SectorHealthcare

IndustryBiotechnology

Market cap$4.88B

P/E ratioNone

EPS$-4.74

Beta1.759

Dividend yield0.00%

52-week high$75.06

52-week low$44.12

ETFs holding CRSP

ARKK 4.50% of the fund RSI 40

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 IOVA Iovance Biotherapeutics Inc RSI 30 IBRX ImmunityBio Inc RSI 44 VKTX Viking Therapeutics Inc RSI 48 TARS Tarsus Pharmaceuticals Inc RSI 55 ATAI ATAI Life Sciences N.V. RSI 62 MRVI Maravai LifeSciences Holdings Inc - Class A RSI 54 BMRN Biomarin Pharmaceutical Inc RSI 55 AUPH Aurinia Pharmaceuticals Inc RSI 49

30 days of PRO Unlimited free, no card

RSI alerts for CRSP

An email when CRSP closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 8:55 PM EDT